But the journey doesnt end when the scale hits your goal
As Medicare coverage expansions in 2025 and 2026 extend GLP-1 drugs to millions of older Americans for the first time, researchers and clinicians are urging a different approach for this age group: more careful baseline assessment, slower dosing, higher protein targets, and proactive monitoring for muscle loss, malnutrition, and bone density decline
It's all about the dollars." "When someone tells you, 'it's not the money, it's the principles,' [it's the] the money," she says
Furthermore, it has been reported that the administration of exenatide attenuates the renal inflammation index, including reducing the TNF-, IL-6, hsCRP, and CCL5 levels, in STZ-induced diabetic rats by increasing the superoxide dismutase and decreasing malondialdehyde levels (Wang et al., 2019)
This multidisciplinary consensus statement developed after a systematic review and modified Delphi process provides current evidence-based recommendations for perioperative care of these patients
Nobody could have predicted the vogue for GLP-1 drugs, which were originally designed to treat Type 2 diabetes